A novel non-opioid protocol for medically supervised opioid withdrawal and transition to antagonist treatment.
CONCLUSION: This retrospective chart review suggests the feasibility of a novel protocol for medically supervised opioid withdrawal and transition to relapse prevention strategies, including injectable ER naltrexone. This withdrawal protocol does not utilize opioid agonists or other controlled substances..
PMID: 28795846 [PubMed - as supplied by publisher]
Source: The American Journal of Drug and Alcohol Abuse - Category: Addiction Authors: Rudolf G, Walsh J, Plawman A, Gianutsos P, Alto W, Mancl L, Rudolf V Tags: Am J Drug Alcohol Abuse Source Type: research
More News: Addiction | Alcoholism | Gabapentin | Hydroxyzine | Neurontin | Substance Abuse | Tizanidine